1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine

• UNSPSC Description:

  1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/1-2-3-dideoxy-β-d-erythro-hexo-pyranosyl-cytosine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N([C@H]2[C@@](O)(C)[C@H](O)[C@@H](CO)O2)C=CC(N)=N1

• Molecular Weight:

  257.24

• References & Citations:

  [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  136020-18-3